Medical Oncology

Vanderbilt   

Questions discussed in this category



Would you consider it for a patient who had bulky thoracic disease, only a single extrathoracic site of involvement and achieved a CR after induction ...

Is immunotherapy plus chemotherapy now standard of care for small cell lung cancer, even though overall survival differences are small? Are there any ...

High enough risk to justify anthracycline+taxane chemotherapy followed by ovarian suppression + aromatase inhibition.


Papers discussed in this category


J Clin Oncol, 1999 Jul

Lancet, 2015 Jan 3

N. Engl. J. Med., 2019 Sep 28

The New England journal of medicine, 2018-12-06